PFE

Pfizer
D

PFE

24.185
USD
0.07
(0.27%)
Market Closed
Volume
1,007,193
EPS
3
Div Yield
7.06
P/E
17
Market Cap
137,164,133,540
Signals
هشام منسي
هشام منسي
7 months ago
buy
PFE
PFE@29.62
2024-09-12 08:22
PFE@29.62 Chart
Profit
-108.75
sara abdelazim
sara abdelazim
1 year ago
buy
PFE
PFE@36.61
2023-08-24 10:20
PFE@36.61 Chart
Profit
-457.50
sara abdelazim
sara abdelazim
1 year ago
buy
PFE
PFE@35.38
2023-08-16 07:49
PFE@35.38 Chart
Profit
16.50
More
Related Instruments
ABT
ABT
1.930
(1.47%)
132.820 USD
AZN
AZN
1.940
(2.75%)
72.440 USD
BMY
BMY
1.000
(2.02%)
50.560 USD
GILD
GILD
0.420
(0.41%)
103.660 USD
GSK
GSK
-0.120
(-0.31%)
39.070 USD
JNJ
JNJ
1.720
(1.11%)
156.120 USD
LLY
LLY
10.33
(1.27%)
823.96 USD
MRK
MRK
-0.090
(-0.11%)
83.160 USD
NVS
NVS
3.000
(2.69%)
114.320 USD
REGN
REGN
15.98
(2.71%)
606.12 USD
SNY
SNY
1.360
(2.51%)
55.470 USD
More
News

Title: Pfizer

Sector: Healthcare
Industry: Drug Manufacturers - General
Pfizer Inc. is a large research-based pharmaceutical and biomedical company. As an American multinational firm, it researches and develops medicines and vaccines for immunology, oncology, cardiology, endocrinology and neurology. The company was established in 1849 in New York by two German businessmen, Charles Pfizer and Charles F. Erhart. Pfizer Inc. is headquartered in New York City and has appeared in the top 50 companies on the Forbes Global 2000 list.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.